Stock DNA
Medical/Nursing Services
CAD 16 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.19
-466.08%
3.48
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - May 2024)
Net Profit:
-5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
66.67%
0%
66.67%
6 Months
11.11%
0%
11.11%
1 Year
-65.52%
0%
-65.52%
2 Years
-81.48%
0%
-81.48%
3 Years
-91.8%
0%
-91.8%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Numinus Wellness, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
86.33%
EBIT Growth (5y)
-278.40%
EBIT to Interest (avg)
-16.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
1.03
Tax Ratio
0.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.48
EV to EBIT
-0.79
EV to EBITDA
-0.90
EV to Capital Employed
4.07
EV to Sales
0.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-514.97%
ROE (Latest)
-466.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : May 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 5 Foreign Institutions (0.9%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - May'24 - QoQ
May'24
Feb'24
Change(%)
Net Sales
4.30
5.00
-14.00%
Operating Profit (PBDIT) excl Other Income
-3.50
-4.40
20.45%
Interest
0.10
0.20
-50.00%
Exceptional Items
0.00
-0.70
100.00%
Consolidate Net Profit
-5.10
-6.00
15.00%
Operating Profit Margin (Excl OI)
-909.70%
-1,002.80%
9.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended May 2024 is -14.00% vs -15.25% in Feb 2024
Consolidated Net Profit
QoQ Growth in quarter ended May 2024 is 15.00% vs -36.36% in Feb 2024
Annual Results Snapshot (Consolidated) - Aug'23
Aug'23
Aug'22
Change(%)
Net Sales
23.20
6.50
256.92%
Operating Profit (PBDIT) excl Other Income
-24.10
-26.90
10.41%
Interest
0.80
0.60
33.33%
Exceptional Items
-2.00
-16.10
87.58%
Consolidate Net Profit
-30.30
-44.90
32.52%
Operating Profit Margin (Excl OI)
-1,163.00%
-4,381.00%
321.80%
USD in Million.
Net Sales
YoY Growth in year ended Aug 2023 is 256.92% vs 333.33% in Aug 2022
Consolidated Net Profit
YoY Growth in year ended Aug 2023 is 32.52% vs -138.83% in Aug 2022
About Numinus Wellness, Inc. 
Numinus Wellness, Inc.
Medical/Nursing Services
Numinus Wellness Inc. (Numinus) is a Canada-based health care company focused on creating an ecosystem of wellness solutions through access, research, training and therapies centered on psychedelic therapies. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer’s license. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer’s license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus also operates a stand-alone center offering patients integrative health solutions.
Company Coordinates 
Company Details
1746 Macdonald St , VANCOUVER BC : V6K 3X8
Registrar Details






